BEYOND THE SLIDE PODCAST: FINDING THE HER2 LOW PATIENT WITH PROF. FRAN BOYLE AND DR. SANJEEV KUMAR
EXCLUSIVE TO THE ONCOLOGY NETWORK
If you would like to access this exclusive HCP-only resource, head over to The Oncology Network and sign up - FREE forever for HCPs only.
Interval breast cancer: understanding risks and the need for enhanced screening
Breast cancer screening through mammography has long been a cornerstone of early detection and mortality…
Prostate cancer and erectile function: NeuroSAFE technique enhances postoperative outcomes in robot-assisted radical prostatectomy
A recent phase 3 trial published in The Lancet Oncology has demonstrated that the NeuroSAFE…
High levels of traumatic stress found in caregivers of adult cancer patients
Every year, millions of family members and friends provide care for loved ones undergoing cancer…
The OJC Meets Ashray Gunjur: Revolutionising Cancer Treatment with Microbiome Intelligence
The Oncology Podcast, part of The Oncology Network, is proud to present the return of The OJC Meets: sister series of The Oncology Journal Club podcast. Our…
Recent Events
-
-
-
CACC 25: Colorectal cancer linked with increased risk of cardiovascular mortality
-
EAU 2025: Worse outcomes for men who avoid prostate cancer screening
-
ASCO GU 2025: Some kidney cancer patients can stop combination treatment after two years
-
-
-
-
ASCO GU 2025: ENZA-p combination treatment improves survival for metastatic prostate cancer
-
Industry Spotlight
FEATURED PODCAST
EXCLUSIVE TO THE ONCOLOGY NETWORK
If you would like to access this exclusive HCP-only resource, head over to The Oncology Network and sign up - FREE forever for HCPs only.
How AI could dramatically improve cancer patients’ prognosis
Frédéric Jallat, PhD, ESCP Business School With 1.2 million deaths in the 2020, or 23% of the total number of…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.
JOIN THE ONCOLOGY NETWORK
Collaborators highlights global trends in risk factors linked to lung cancer deaths
- Researchers make economic case for a national lung cancer screening programme in Australia
- Pharmacokinetics comparison of aumolertinib, osimertinib, gefitinib and their major metabolites in mouse model and NSCLC patients
- Diabetes drug appears to target lung cancer — but only in overweight or obese patients
